|
|
Article: Reduced allopregnanolone levels during luteal phase may contribute to PMS.
- Article from:
- Women's Health Weekly
- Article date:
- June 3, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JUN 3 - (NewsRx.com & NewsRx.net) -- A study comparing various hormone levels between women with premenstrual syndrome (PMS) those without suggests impaired production of allopregnanolone during the luteal phase of the menstrual cycle may contribute to the mood disorders PMS patients experience.
"Several studies have been performed during recent years to investigate the existence of a possible endocrine cause for premenstrual syndrome; the results reported are often discordant. Great interest has been raised around allopregnanolone, which could be involved in the determination of mood disorders reported by PMS patients. During the luteal phase, lower levels ...